Key Points
- Bayview Legacy sold 40,000 shares of Arteris (NASDAQ:AIP) on Dec. 4 at an average price of $16.46 for proceeds of $658,400, and still directly owns 9,599,071 shares (valued at about $158M), a 0.41% reduction in its stake.
- The Dec. 4 sale follows two October dispositions (100,000 shares on Oct. 6 at $13.10 and 50,000 on Oct. 8 at $13.07), bringing recent insider sales to 190,000 shares for roughly $2.62M in total proceeds.
- Arteris has a market cap of about $794M, a 52‑week range of $5.46–$18.21, reported Q3 EPS of -$0.09 beating estimates with $17.41M revenue, and carries a consensus analyst rating of “Moderate Buy” with an average price target of $17.50.
Arteris, Inc. (NASDAQ:AIP - Get Free Report) VP Paul Alpern sold 7,500 shares of the business's stock in a transaction dated Thursday, December 4th. The shares were sold at an average price of $16.09, for a total transaction of $120,675.00. Following the completion of the transaction, the vice president owned 65,277 shares in the company, valued at $1,050,306.93. The trade was a 10.31% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Arteris Stock Performance
Shares of Arteris stock opened at $18.18 on Tuesday. The stock has a 50 day moving average of $13.75 and a 200 day moving average of $10.77. The firm has a market capitalization of $794.10 million, a price-to-earnings ratio of -21.90 and a beta of 1.48. Arteris, Inc. has a fifty-two week low of $5.46 and a fifty-two week high of $18.21.
Arteris (NASDAQ:AIP - Get Free Report) last posted its earnings results on Tuesday, November 4th. The company reported ($0.09) EPS for the quarter, beating analysts' consensus estimates of ($0.11) by $0.02. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.25%.The company had revenue of $17.41 million for the quarter, compared to the consensus estimate of $17.00 million. Analysts forecast that Arteris, Inc. will post -0.73 EPS for the current year.
Institutional Investors Weigh In On Arteris
A number of hedge funds have recently added to or reduced their stakes in the business. Penn Capital Management Company LLC purchased a new position in Arteris in the third quarter valued at $109,000. Worth Venture Partners LLC raised its position in Arteris by 24.2% in the 3rd quarter. Worth Venture Partners LLC now owns 58,731 shares of the company's stock valued at $593,000 after purchasing an additional 11,446 shares in the last quarter. Westerly Capital Management LLC raised its position in Arteris by 109.6% in the 3rd quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company's stock valued at $14,392,000 after purchasing an additional 745,000 shares in the last quarter. Susquehanna Fundamental Investments LLC purchased a new position in shares of Arteris in the 3rd quarter valued at about $113,000. Finally, Public Employees Retirement System of Ohio grew its position in shares of Arteris by 12.3% during the third quarter. Public Employees Retirement System of Ohio now owns 23,913 shares of the company's stock worth $242,000 after buying an additional 2,613 shares in the last quarter. 64.36% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several research analysts have weighed in on AIP shares. Jefferies Financial Group raised shares of Arteris to a "hold" rating in a research note on Tuesday, October 28th. Wall Street Zen raised shares of Arteris from a "sell" rating to a "hold" rating in a research report on Monday, September 15th. Rosenblatt Securities boosted their target price on Arteris from $14.00 to $20.00 and gave the company a "buy" rating in a research report on Wednesday, November 5th. TD Cowen upped their price target on Arteris from $15.00 to $16.50 and gave the stock a "buy" rating in a research note on Wednesday, November 5th. Finally, Cowen restated a "buy" rating on shares of Arteris in a research report on Wednesday, November 5th. Four research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $17.50.
View Our Latest Stock Analysis on Arteris
Arteris Company Profile
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
